ClinicalTrials.gg
CompletedNCT06233188Updated Jan 31, 2024

Effect of Customized Lateral Nasal Wall Osteotomy on the Pterygomaxillary Separation During le Fort I Down-fracture

An interventional study of orthogantic surgery in Malocclusion, Open Bite and Le Fort; I, sponsored by Bezmialem Vakif University. Completed at 1 site in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-01-31.

Primary conditionOpen BiteRegistry: MalocclusionReclassifiedWhy we changed it
Registry
Malocclusion — the first condition term the registry derived for this study.
ClinicalTrials.gg
Open Bite
Why
  1. The study's listed conditions name Open Bite, a narrower term within Malocclusion.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Bezmialem Vakif University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled May 2023, registered Jan 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
43
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to show the effect of patient specific lateral nasal wall osteotomy to the pterygomaxillary separation during Le Fort I down-fracture.

Participants will be divided into two treatment groups. In study group, surgery planned according to the patients' indivudial anatomy and in the conventional group, surgery planned according to mean anatomical datas.

Researchers will compare patient specific lateral nasal wall osteotomy to see if it affects the pterygomaxillary junction seperation during le fort I downfracture.

Read the detailed description

The same surgical team performed the osteotomies under general anesthesia with nasotracheal intubation. Hypotensive anesthesia was applied as a standard protocol in all patients. Orthognathic surgery, including Le Fort I and sagittal split ramus osteotomy, was used to correct skeletal deformities.

Bone osteotomy was initiated on the bilateral wall of the maxilla with piezosurgery after a mucosal incision and flap elevation.Lateral nasal osteotomy (LNO) with Nievert Anderson single guarded osteotome, median septum separation with double guarded U-shaped osteotome, and pterygomaxillary junction separation with curved osteotome were performed before the down-fracture. The only difference between the conventional and study groups was the depth of the LNO. In the study group, LNO was performed at a depth of 2 mm less than the measured distance in the axial section. In the conventional osteotomy group, LNO was performed at 30 mm for females and 35 mm for males, as suggested in the literature. A curved osteotome and a mallet were used in each case to separate the pterygomaxillary junction. The down-fracture of the maxilla was performed using a hook and a bone spreader in all patients. When the maxilla was down-fractured, LNW and the pterygomaxillary separation types were assessed intraoperatively. The maxilla was stabilized in its new position by four L-shaped osteosynthesis mini-plates at the zygomaticomaxillary buttress and the aperture piriformis regions.

02

Conditions studied

  • Malocclusion
  • Open Bite
  • Le Fort; I
  • Orthognathic Surgery

Browse trials for

Keywords

  • orthognatic surgery
  • le fort I
  • arterial bleeding
  • down fracture
  • lateral nasal wall
  • pterygomaxillary junction
03

In context

Open Bite Reclassified

34 studies on the registry are indexed under Open Bite; 8 are open to participants now.

This study's enrollment of 43 is above the median of 30 across 28 interventional studies indexed under Open Bite.

Browse Open Bite studies →

Lead sponsor

Bezmialem Vakif University is the lead sponsor of 354 studies on the registry; 59 are open to participants now.

Compared within Open Bite, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Malocclusion. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria: The inclusion criteria

  • orthognathic surgery to treat malocclusion
  • sleep apnea
  • jaw asymmetry

Exclusion Criteria:

  • cleft lip and palate
  • previous orthognathic surgery
  • rhinoplasty
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
43 participants (actual)

Study arms

  • Active comparator
    study group

    In the study group, lateral nasal osteotomy was performed 2 mm less than the measured distance in the axial section

    Procedure: orthogantic surgery

  • Active comparator
    conventional group

    n the conventional osteotomy group, lateral nasal osteotomy was performed 25 mm for female and 30 mm for male patients, as suggested in the literature.

    Procedure: orthogantic surgery

Interventions

  • Procedureorthogantic surgery

    surgery that correcting the maxilla and mandible related with each other

06

What researchers measure

Primary outcomes

  1. lateral nasal wall separation

    The primary outcome variable is lateral nasal wall separation: Type 1 Separation from the osteotomy line Type 2 Separation 2-4 mm above the osteotomy line Type 3 Separation 4 mm or more above the osteotomy line

    Time frame: 1 year

Secondary outcomes

  1. pterygomaxillary junction separation

    The secondary outcome variable is pterygomaxillary separation Type 1 Separation including the tuber maxilla Type 2 Separation from the pterygomaxillary junction Type 3 Separation including the pterygoid plates

    Time frame: 1 year

07

Study locations

1 site
  • Taha Pergel
    Istanbul, Fatih 34093, Turkey
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 31, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06233188
Responsible party
Taha Pergel (Assistant Profesor, Bezmialem Vakif University) — Principal investigator
First posted
Jan 31, 2024
Start date
May 3, 2023
Primary completion
Oct 15, 2023
Completion
Dec 5, 2023
Last update
Jan 31, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion